Clin2
NCT07128992Possibly a fitNot yet recruiting

Need-driven treatment for type 1 diabetes

Type 1 Diabetes (T1D)Glucose Control

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This trial tests a new way to manage type 1 diabetes by tailoring treatment based on your personal needs and glucose data. You'll share data from your continuous glucose monitor with the diabetes team at Tampere University Hospital and receive remote care instead of in-person visits.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
125 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have had type 1 diabetes for at least one year
  • You use multiple daily injections or an insulin pump
  • You use a continuous glucose monitor linked to a smartphone app
  • You are under diabetes care in the Pirkanmaa region (Finland)
  • You have had good blood sugar control recently and no major diabetes complications in the past year

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07282639Not yet recruiting
App-based diabetes education for type 1 diabetes

This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.

La Jolla, California
NCT07507708Recruiting
Smart insulin system with behavior support for type 1 diabetes

This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.

Charlottesville, Virginia
NCT06977633Not yet recruiting
Testing a new glucose-ketone sensor for type 1 diabetes

This study tests a device that measures both glucose and ketone levels continuously. It may help people with type 1 diabetes better manage their condition by providing real-time data.

Palo Alto, California
NCT07186660Recruiting· Phase 2
Studying a new insulin sensitizer for type 1 diabetes

This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.

Charlottesville, Virginia
NCT07679347Not yet recruiting
Testing a new continuous glucose monitor for type 1 diabetes

This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.

NCT07258758Recruiting
Personalized nutrition education for type 1 diabetes

This trial tests a person-centered nutrition education program designed to help adults with type 1 diabetes improve blood sugar control. It focuses on providing individual dietary guidance that fits your lifestyle and preferences.

Enköping, Uppland

Hear when a new Glucose Control trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.